Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Care Twentyone's 3-Year RORE % for the quarter that ended in Apr. 2026 was -168.22%.
The industry rank for Care Twentyone's 3-Year RORE % or its related term are showing as below:
TSE:2373's 3-Year RORE % is ranked worse than 94.68% of 602
companies
in the Healthcare Providers & Services industry
Industry Median: 0.195
vs TSE:2373: -168.22
Care Twentyone (TSE:2373) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Care Twentyone 3-Year RORE % Related Terms
Care Twentyone 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Care Twentyone's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2373 vs HCA, THC, DVA: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, Care Twentyone's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Care Twentyone 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Care Twentyone's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Care Twentyone's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Apr. 2026 and 3-year before.
Care Twentyone (TSE:2373) has a 3-Year RORE % of -168.22 as of Apr. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Care Twentyone and its competitors. According to the industry distribution chart, Care Twentyone ranks #570 out of 602 companies in the Healthcare Providers & Services industry, placing it in the top 94.7%.
Is Care Twentyone's 3-Year RORE % too high?
Care Twentyone's current 3-Year RORE % is -168.22. Based on the distribution chart, Care Twentyone ranks #570 out of 602 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Care Twentyone has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Care Twentyone's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Care Twentyone ranks #570 out of 602 companies for 3-Year RORE %. This places Care Twentyone in the lower half of its industry. The industry median 3-Year RORE % is 0.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 602 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Care Twentyone and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Care Twentyone's current 3-Year RORE % is -168.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Care Twentyone stock overvalued right now?
Based on GuruFocus' analysis, Care Twentyone (TSE:2373) is currently considered Modestly Undervalued. The stock's GF Value™ is 円481.17, compared to a current price of 円403.00 — trading 16.2% below its estimated fair value. The current 3-Year RORE % is -168.22. Care Twentyone's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Care Twentyone (TSE:2373), the current 3-Year RORE % is -168.22 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Care Twentyone (TSE:2373) Overvalued in 2026?
Based on GuruFocus' analysis, Care Twentyone stock appears to be undervalued.
The current stock price of 円403.00 is trading 16.2% below its estimated GF Value™ of 円481.17.
GuruFocus considers Care Twentyone to be Modestly Undervalued.
Key valuation signals for TSE:2373:
3-Year RORE %: -168.22
GF Value™: 円481.17 vs. price of 円403.00 (16.2% below fair value)
No single metric tells the full story. See the TSE:2373 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Care Twentyone Corp provides nursing care services. It also leases and sells nursing equipment as well as operates a nursing home for the elder people. It also provides daycare homes, nursing homes, and group homes. It is also engaged in small-scale multifunctional home care, welfare equipment sales, rental and housing repair and light work contracting business. The company has two reportable segments based on its business model: In-home nursing care business; and Facility-based nursing care business. The home care business provides visiting care services, home care support services, day care services, etc. The Facility-based Nursing Care Business operates paid nursing homes and group homes.
59GF Score
Get the complete analysis for TSE:2373
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2373 has been successfully added to your 
